Trial
NCT04864977
A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Type 2 Diabetes
Intervention
Basal Insulin
Why stopped
Study was stopped prior to study start date due to business decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-24